Avicanna's Executive Vice President Research and Product Development Dr. Frantz Le Devedec joins Natalie Stoberman from the Proactive studio to discuss the company's commercialization of patent-pending, water-soluble technology "Influid".
Avicanna is a commercial-stage international biopharmaceutical company focused on the advancement and commercialization of evidence-based cannabinoid-based products for the global medical and pharmaceutical market segments.